Table III.
CTC-PV/CTM-PV counts of 8 patients with lung cancer who received induction chemotherapy.
| Patient no. | Histology | cTNM | Chemotherapy regimen | No. of cycles | Response | ypTNM | Residual tumor (%) | CTC-PV | CTM-PV |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Squamous | cT2bN0M0 | GP | 1 | PR | ypT1bN0M0 | 20 | 0 | 0 |
| 2 | Adenocarcinoma | cT2aN0M0 | TP | 3 | PR | ypT1aN0M0 | 95 | 1 | 0 |
| 3 | Squamous | cT3N1M0 | GP | 2 | PR | ypT3N0M0 | 95 | 3 | 0 |
| 4a | Squamous | cT2aN2M0 | GP | 2 | PR | ypT2aN2M0 | 95 | 8 | 0 |
| 5 | Squamous | cT3N0M0 | GP | 2 | PR | ypT2aN0M0 | 95 | 16 | 1 |
| 6 | Squamous | cT3N2M0 | GP | 2 | PR | ypT2aN0M0 | 80 | 23 | 0 |
| 7 | Large cell | cT3N1M0 | GP | 2 | SD | ypT3N0M0 | 30 | 214 | 4 |
| 8 | Squamous | cT3N1M0 | GP | 2 | SD | ypT3N1M0 | 80 | 8,000 | 48 |
a
Computed tomography images of this patient are shown in Fig. 3F and G. PR, partial response; SD, stable disease; GP, gemcitabine/platinum; TP, paclitaxel/platinum; cTNM, clinical tumor-node-metastasis; ypTNM, pathological tumor-node-metastasis following therapy; CTC, circulating tumor cell; CTM, circulating tumor microemboli; PV, pulmonary vein.